![](https://www.aptitudehealth.com/wp-content/uploads/2021/09/Cancer-Cell-11-Mobile.jpg)
Insights Into Testing Protocols and Treatment Pathways for NTRK Fusion-Positive Cancers
Perspectives of community physicians from across the US on optimal integration and side effect management of novel therapies
![](https://www.aptitudehealth.com/wp-content/uploads/2021/09/Dr-Schwartzberg-MD-FACP-Aptitude-Health.jpg)
Faculty Chair
Lee Schwartzberg, MD, FACP
West Cancer Center, Memphis, TN
More Information
- Virtual series
REPORT SNAPSHOT
- NTRK Gene Fusions as Oncogenic Drivers
- Treatment of Thyroid/Salivary Gland Cancers
- Consensus Pathway Discussion: Thyroid/Salivary Gland Cancers
- Treatment of Lung Cancer
- Consensus Pathway Discussion: Lung Cancer
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection was accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprised 10–15 medical oncologists